Systemic sclerosis associated myopathy
- PMID: 36549354
- DOI: 10.1016/j.autrev.2022.103261
Systemic sclerosis associated myopathy
Abstract
Scleroderma associated myopathy (SScAM) is a common but heterogeneous musculoskeletal manifestation of systemic sclerosis (SSc) for which there is still no clear definition. Still, SScAM is associated with disability, poor quality of life and mortality. This review discusses the most updated literature of SScAM including clinical and antibody associations, recent updates on histopathological findings, prognosis and treatment.
Keywords: Fibrosis; Myopathy; Myositis; Prognosis; Systemic sclerosis; Systemic sclerosis associated myopathy; Vasculopathy.
Copyright © 2022 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest None.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical